These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1376715)

  • 1. A single human monoclonal antibody that confers total protection from tetanus.
    Arunachalam B; Ghosh S; Talwar GP; Raghupathy R
    Hybridoma; 1992 Apr; 11(2):165-79. PubMed ID: 1376715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.
    Ziegler-Heitbrock HW; Reiter C; Trenkmann J; Fütterer A; Riethmüller G
    Hybridoma; 1986; 5(1):21-31. PubMed ID: 2420699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
    Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
    Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective human hybridoma antibody to tetanus toxin.
    Gigliotti F; Insel RA
    J Clin Invest; 1982 Dec; 70(6):1306-9. PubMed ID: 7174795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective murine monoclonal antibodies to tetanus toxin.
    Shang HF; Liau MY; Chow MF; Jiang SY; Chen SC; Yeh MY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):199-209. PubMed ID: 3151481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of hybridomas secreting human monoclonal antibodies against tetanus toxin and hepatitis B virus surface antigen.
    Ichimori Y; Sasano K; Itoh H; Hitotsumachi S; Kimura Y; Kaneko K; Kida M; Tsukamoto K
    Biochem Biophys Res Commun; 1985 May; 129(1):26-33. PubMed ID: 2408619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel linear epitope in tetanus toxin recognized by a protective monoclonal antibody: implications for vaccine design.
    Luo P; Qin L; Mao X; Chen L; Yu S; Li Q; Liu W; Zhang W; Gu J; Zou Q
    Vaccine; 2012 Oct; 30(45):6449-55. PubMed ID: 22889825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C.
    Gustafsson B; Whitmore E; Tiru M
    Hybridoma; 1993 Dec; 12(6):699-708. PubMed ID: 8288271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin.
    Lang AB; Cryz SJ; Schürch U; Ganss MT; Bruderer U
    J Immunol; 1993 Jul; 151(1):466-72. PubMed ID: 8326138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of a neutralizing murine monoclonal antibody against tetanus toxin.
    Li Y; Chen Y; Cui J; Liu D; Zhang W; Xue C; Xiong X; Liu G; Chen H
    J Immunol Methods; 2023 Feb; 513():113427. PubMed ID: 36652969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
    Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
    Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human monoclonal antibody specific for tetanus toxoid.
    Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
    Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies to tetanus toxin.
    Sheppard AJ; Cussell D; Hughes M
    Infect Immun; 1984 Feb; 43(2):710-4. PubMed ID: 6198285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA; Sviridov VV; Perelygina OV
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key protection factors against tetanus: Anti-tetanus toxin antibody affinity and its ability to prevent tetanus toxin - ganglioside interaction.
    Lukić I; Marinković E; Filipović A; Krnjaja O; Kosanović D; Inić-Kanada A; Stojanović M
    Toxicon; 2015 Sep; 103():135-44. PubMed ID: 26140841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against tetanus toxin and toxoid.
    Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
    Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
    Simpson LL; Lake P; Kozaki S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.